Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, has appointed Andrew M. Ibrahim, MD, MSc, as its new Chief Clinical Officer (CCO).
In this role, Dr. Ibrahim will shape the company’s clinical strategy and guide the integration of generative artificial intelligence into healthcare delivery, with the goal of enhancing quality, efficiency, and patient outcomes. He will report directly to Chris Mansi, MD, CEO and co-founder of Viz.ai.
Dr. Ibrahim is a board-certified general surgeon and internationally recognized authority in healthcare delivery. With over 200 scientific publications to his credit, he has secured research funding from the National Institutes of Health and the Agency for Healthcare Research and Quality. His influential work has been published in leading journals such as JAMA, Health Affairs, and NEJM Catalyst, and he has delivered invited lectures across five continents. Later this month, he will testify before Congress on AI regulation and reimbursement.
Currently, Dr. Ibrahim holds the George D. Zuidema Professorship at the University of Michigan, where he practices general surgery and conducts pioneering research at the intersection of surgery, healthcare delivery, and innovation. He is also widely recognized as the creator of the “Visual Abstract,” a breakthrough in scientific communication now adopted by more than 100 medical journals worldwide.
Previously, Dr. Ibrahim served as Chief Medical Officer and Senior Principal at HOK, overseeing healthcare and life sciences design projects valued at over $4 billion. He earned his medical degree from Case Western Reserve University and completed surgical training and a master’s in Healthcare Delivery at the University of Michigan.
.webp "AngioInsight Appoints Medtech Veteran Shlomi Nachman to Board of Directors")
